d-LIVER Workshop: Improving Clinical Care and Patient Quality of Life in Advanced Liver Disease

27 May 2015, Milan, Italy.
The d-LIVER project announces a Showcase Workshop to introduce new technological solutions to improve clinical care and patient quality of life in advanced liver disease. d-LIVER has developed a home monitoring system for remote patient management and a bio-artificial liver support device. The home monitoring system will support patients with advanced liver disease using regular patient-led measurements of physiological parameters (including heart rate and blood pressure) and six blood biochemistry tests. An ICT-enabled system allows semi-automated optimisation of therapy with support from specialist clinicians, where required. It is envisaged that this system will allow the earlier detection of decompensation leading to improved clinical outcomes, improved patient quality of life and reduced costs of management.

The bio-artificial liver technology includes identification of a reliable and cost effective source of functional hepatocytes, derived from readily expandable progenitors, to carry out detoxification and other hepatic functions in an acute setting. A three-dimensional bioreactor will provide an environment in which these cells can be supported and monitored during the perfusion of serum from patients undergoing support.

The Workshop is designed to showcase the developed technologies and to learn how these new technologies might fit in to current and future clinical practice. It addresses liver specialists at large liver centres but also other interested healthcare specialists including general practitioners (GPs), technology integrators and developers, health service and health insurance representatives, and patient representatives.

The Workshop is co-organised with the NanoBio4Trans project and will take place on May 27th 2015 at the Humanitas Research Hospital Congress Centre in Milan, Italy. Participation is free of charge but registration is required at www.d-liver.eu/showcase2015/.

About d-LIVER
The d-LIVER project addresses the need for an ICT enabled bio-artificial liver support system (BAL) to facilitate detoxification as remote transient therapy at the point of need, offering continuous care from hospital to home settings. The overall goal of the project is to provide safe and cost-effective systems for continuous, context-aware, multi-parametric monitoring of both patient and BAL system parameters in order to: enhance the quality of medical treatment and management; improve the quality of life for patients; reduce the incidence and duration of hospitalization and consequently reduce the health economic burden of chronic liver disease. d-LIVER will facilitate improved treatment whilst enabling patients to spend more time at home under constant, albeit remote, medical supervision. The d-LIVER project is coordinated by Newcastle University (Prof. Calum McNeil) and funded by the European Union 7th Framework Programme.

About NanoBio4Trans
The aim of the NanoBio4Trans project is to develop, optimize and validate a highly vascularised in vivo-like extracorporeal bio-artificial liver, which is ready to be perfused with human blood plasma, and can be exploited in modern medical technology. The aim of the first version of the artificial liver is to support patients with weak liver function with an external bio-artificial liver; this should be ready in 2020. The NanoBio4Trans project is funded by the European Union 7th Framework Programme.

Most Popular Now

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

To be Happier, Take a Vacation... from Y…

Today, nearly every American - 91% - owns a cellphone that can access the internet, according to the Pew Research Center. In 2011, only about one-third did. Another study finds...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI Revolutionizes Glaucoma Care

Imagine walking into a supermarket, train station, or shopping mall and having your eyes screened for glaucoma within seconds - no appointment needed. With the AI-based Glaucoma Screening (AI-GS) network...

North Cumbria Integrated Care Signs 10-Y…

North Cumbria Integrated Care NHS Foundation Trust (NCIC) has signed a long-term agreement for use of the Alcidion Miya Precision platform, to provide an electronic patient record (EPR) for the...

AI Accelerates Discovery of Neurodevelop…

Researchers have developed an artificial intelligence (AI) approach that accelerates the identification of genes that contribute to neurodevelopmental conditions such as autism spectrum disorder, epilepsy and developmental delay. This new...